Yang, Jianzhou <br/><br/>
Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight.  [electronic resource] 

 -  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases  May 2011 
 - e336-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3511 
<br/><br/><label>Standard No.: </label>10.1016/j.ijid.2011.01.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Anti-Infective Agents--adverse effects<br/>Chronic Disease<br/>Cohort Studies<br/>Confidence Intervals<br/>Databases, Factual<br/>Drug Prescriptions--statistics & numerical data<br/>Female<br/>Humans<br/>Infant, Low Birth Weight<br/>Infant, Newborn<br/>Infant, Premature<br/>Logistic Models<br/>Parity<br/>Pregnancy<br/>Pregnancy Complications, Infectious--drug therapy<br/>Premature Birth--chemically induced<br/>Retrospective Studies<br/>Risk Factors<br/>Saskatchewan--epidemiology<br/>Socioeconomic Factors<br/>Trimethoprim, Sulfamethoxazole Drug Combination--adverse effects<br/>United States<br/>United States Food and Drug Administration<br/>Young Adult